GeneTex
  • Country / Location Selection

United States (US)
Yellow Fever Virus

Yellow Fever Virus

Yellow Fever Virus

Yellow fever, caused by the mosquito-transmitted yellow fever virus (YFV), is a potentially fatal disease that has plagued humans for centuries. The 17D vaccine, raised against an attenuated strain of YFV, has been available for more than 80 years and provides excellent protection. Nevertheless, significant vulnerability in the world population persists even with vaccination and vector control programs, as exemplified by recent outbreaks in Africa and South America. In addition, the existence of the vaccine may have slowed the impetus to identify therapeutic antivirals to treat symptomatic cases of yellow fever in unvaccinated people. Thus, research into YFV biology and candidate agents that disrupt the viral life cycle remain a world public health priority.

See all related Products


Featured Products

YFV Capsid Protein antibody

YFV Capsid Protein C antibody (GTX134022)

YFV NS4B Protein antibody

YFV NS4B Protein antibody (GTX134030)

YFV NS5 protein antibody

YFV NS5 Protein antibody (GTX134141)

In their recent Antiviral Research study, Gao et al. describe the development of antibody-based assays to facilitate high-throughput discovery of anti-YFV agents. To do this, the researchers first performed an exhaustive analysis on a series of research antibodies from GeneTex that target the three structural and five of the nonstructural proteins encoded by the YFV genome. They used the antibodies for both biochemical and cell biology assays to explore YFV polyprotein processing, replication complex organization, and viral RNA synthesis. The anti-NS4B antibody (GTX134030) was then incorporated into in-cell western and high-content imaging assays that revealed a synergistic antiviral effect of the compounds BDAA and Sofosbuvir, which target NS4B and the NS5 RNA polymerase, respectively. These findings demonstrate how antibody-based assays can not only expedite screening for antiviral agents against YFV, but also provide insight into the mechanistic basis of their inhibitory actions.

GeneTex is a leader in the production of reliable reagents for the study of an array of viral pathogens, including flaviviruses, influenza viruses, enteroviruses, and coronaviruses (i.e., MERS-CoV, SARS-CoV, and SARS-CoV-2), among others. The GeneTex team’s top priority is to create reagents that perform well in the hands of researchers. We are particularly gratified by the impressive results generated by Gao et al. using our YFV antibodies.

References:

Gao et al. Antiviral Res. 2020 Oct; 182: 104907.

Literature

Brochure - Antibodies For Virology Research

Download the latest version of GeneTex's Antibodies For Virology Research brochure.
Literature
Brochure - SARS-CoV-2 (COVID-19) Research

Brochure - SARS-CoV-2 (COVID-19) Research

Download the latest version of GeneTex's SARS-CoV-2 (COVID-19) Research brochure.
Literature

Flyer-Total Solutions of Antibodies for SARS CoV-2

Download the latest version of GeneTex's Total Solutions of Antibodies for SARS CoV-2 flyer.
Newsletter

Recombinant Influenza A & B Virus Antibodies for Lateral Flow Assay

Influenza A & B Virus Antibodies (IVD grade)
Newsletter
Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes
Newsletter
Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies
Literature
Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents

Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents

SARS-CoV-2 (COVID-19) Research Reagents
Newsletter
GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry
Newsletter

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells
Newsletter

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease
Newsletter
IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research
Newsletter
Spike Antibody-mediated Neutralization of SARS-CoV-2

Spike Antibody-mediated Neutralization of SARS-CoV-2

Spike Antibody-mediated Neutralization of SARS-CoV-2
Articles

The concept of a SARS-CoV-2 / COVID-19 rapid test

A rapid virus antigen test detects SARS-CoV-2 particles in samples by capturing viral antigen between a free labeled antibody and a fixed second antibody that each recognize different regions of the antigen.
Articles
SARS-CoV-2 (COVID-19) Spike Variant Recombinant Proteins

SARS-CoV-2 (COVID-19) Spike Variant Recombinant Proteins

Newsletter
SARS-CoV-2 Proteins and Antibodies for Lateral-flow-based Neutralization Assay

SARS-CoV-2 Proteins and Antibodies for Lateral-flow-based Neutralization Assay

for Lateral-flow-based Neutralization Assay
Literature
Download the latest version of GeneTex's Zika Virus Research flyer.

Flyer-ZikaVirusResearch

Download the latest version of GeneTex's Zika Virus Research flyer.
Literature
Selected Antibodies for Influenza Virus

Flyer-Selected Antibodies for Influenza Virus

Download the latest version of GeneTex's Selected Antibodies for Influenza Virus flyer.
Literature
Cited Antibodies

Flyer - Cited Antibodies

Download the latest version of GeneTex's cited antibodies flyer.
Newsletter

SETD3 Is Pivotal for Infection by Multiple Human Enteroviruses

In an exciting example of this concept, Diep et al. described the use of a genome-scale CRISPR screen to show that the protein histidine methyltransferase SETD3 is crucial for the replication of multiple human enteroviruses.
Newsletter
HBV

Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.

Is a cure for chronic hepatitis B on the horizon? Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.
Literature
World Class Validated Antibodies

Brochure - World Class Validated Antibodies

Download the latest version of GeneTex's World Class Validated Antibodies brochure.
Literature

Pamphlet - Antibodies for Virus Research

Download the latest version of GeneTex's antibodies for virus research pamphlet.
Literature
Flavivirus

Flyer - Flavivirus

Download the latest version of GeneTex's flavivirus flyer.
Literature

Pamphlet - Hot Products

Download the latest version of GeneTex's pamphlet of hot products.
Literature

Brochure - Antibodies For Virology Research

Download the latest version of GeneTex's Antibodies For Virology Research brochure.
Literature
Brochure - SARS-CoV-2 (COVID-19) Research

Brochure - SARS-CoV-2 (COVID-19) Research

Download the latest version of GeneTex's SARS-CoV-2 (COVID-19) Research brochure.
Literature

Flyer-Total Solutions of Antibodies for SARS CoV-2

Download the latest version of GeneTex's Total Solutions of Antibodies for SARS CoV-2 flyer.
Literature
Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents

Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents

SARS-CoV-2 (COVID-19) Research Reagents
Literature
Download the latest version of GeneTex's Zika Virus Research flyer.

Flyer-ZikaVirusResearch

Download the latest version of GeneTex's Zika Virus Research flyer.
Literature
Selected Antibodies for Influenza Virus

Flyer-Selected Antibodies for Influenza Virus

Download the latest version of GeneTex's Selected Antibodies for Influenza Virus flyer.
Literature
Cited Antibodies

Flyer - Cited Antibodies

Download the latest version of GeneTex's cited antibodies flyer.
Literature
World Class Validated Antibodies

Brochure - World Class Validated Antibodies

Download the latest version of GeneTex's World Class Validated Antibodies brochure.
Literature

Pamphlet - Antibodies for Virus Research

Download the latest version of GeneTex's antibodies for virus research pamphlet.
Literature
Flavivirus

Flyer - Flavivirus

Download the latest version of GeneTex's flavivirus flyer.
Literature

Pamphlet - Hot Products

Download the latest version of GeneTex's pamphlet of hot products.
Newsletter

Recombinant Influenza A & B Virus Antibodies for Lateral Flow Assay

Influenza A & B Virus Antibodies (IVD grade)
Newsletter
Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes
Newsletter
Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies
Newsletter
GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry
Newsletter

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells
Newsletter

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease
Newsletter
IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research
Newsletter
Spike Antibody-mediated Neutralization of SARS-CoV-2

Spike Antibody-mediated Neutralization of SARS-CoV-2

Spike Antibody-mediated Neutralization of SARS-CoV-2
Newsletter
SARS-CoV-2 Proteins and Antibodies for Lateral-flow-based Neutralization Assay

SARS-CoV-2 Proteins and Antibodies for Lateral-flow-based Neutralization Assay

for Lateral-flow-based Neutralization Assay
Newsletter

SETD3 Is Pivotal for Infection by Multiple Human Enteroviruses

In an exciting example of this concept, Diep et al. described the use of a genome-scale CRISPR screen to show that the protein histidine methyltransferase SETD3 is crucial for the replication of multiple human enteroviruses.
Newsletter
HBV

Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.

Is a cure for chronic hepatitis B on the horizon? Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.